Baroda, India

Periyandi Nagarajan

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Periyandi Nagarajan: Innovating Pharmaceuticals

Introduction

Periyandi Nagarajan is a notable inventor hailing from Baroda, India. He has made significant contributions to the pharmaceutical industry, particularly in the development of processes that enhance drug formulations. With a strong portfolio of three patents, Nagarajan continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents, Nagarajan has developed a process for the preparation of citalopram and its enantiomers. This invention focuses on the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile. The process involves the reaction of a specific compound (referred to as formula IVa) in the presence of a base with another compound outlined in his patent, which promotes efficiency and effectiveness in the synthesis of this important antidepressant.

Career Highlights

Currently, Nagarajan is associated with Sun Pharma Global Fze, where he utilizes his expertise to contribute to groundbreaking pharmaceutical advancements. His work has positioned him as a key player in the development of innovative drug solutions that address various health issues.

Collaborations

Throughout his career, Nagarajan has collaborated with esteemed colleagues such as Kilaru Srinivasu and Thennati Rajamannar. These collaborations have helped to foster a creative and productive environment, facilitating the development of new and effective pharmaceutical processes.

Conclusion

Periyandi Nagarajan's contributions to the field of pharmaceuticals exemplify the spirit of innovation and the importance of intellectual property in advancing health care. His work not only benefits the industry but also enhances the quality of life for patients worldwide. With his ongoing commitment to research and development, Nagarajan is sure to continue making impactful strides in the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…